InnoCare Pharma Ltd. (HK:9969)
:9969
Want to see HK:9969 full AI Analyst Report?
9969 Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
9969 Stock 12 Month Forecast
Average Price Target
HK$19.86
▲(68.98% Upside)
| Highest Price TargetHK$21.40 | Average Price TargetHK$19.86 | Lowest Price TargetHK$18.31 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
CMB International Securities
HK$11.95→HK$18.31
Buy
55.83%
Upside
Reiterated
04/24/26
Unknown Analyst
Guoyuan Securities (HK)Not Ranked
Guoyuan Securities (HK)
HK$16.81
Buy
43.06%
Upside
Reiterated
12/24/25
Morgan Stanley
HK$19.6
Hold
66.81%
Upside
Reiterated
11/20/25
Goldman Sachs
HK$20.59→HK$22.89
Buy
94.81%
Upside
Reiterated
10/09/25
Unknown Analyst
Guotai HaitongNot Ranked
Guotai Haitong
HK$26.7
Buy
127.23%
Upside
Reiterated
09/23/25
Unknown Analyst
SPDBNot Ranked
SPDB
HK$21
Buy
78.72%
Upside
Reiterated
08/26/25
Unknown Analyst
CICCNot Ranked
CICC
HK$12.41
Buy
5.62%
Upside
Reiterated
05/21/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
CMB International Securities
HK$11.95→HK$18.31
Buy
55.83%
Upside
Reiterated
04/24/26
Unknown Analyst
Guoyuan Securities (HK)Not Ranked
Guoyuan Securities (HK)
HK$16.81
Buy
43.06%
Upside
Reiterated
12/24/25
Morgan Stanley
HK$19.6
Hold
66.81%
Upside
Reiterated
11/20/25
Goldman Sachs
HK$20.59→HK$22.89
Buy
94.81%
Upside
Reiterated
10/09/25
Unknown Analyst
Guotai HaitongNot Ranked
Guotai Haitong
HK$26.7
Buy
127.23%
Upside
Reiterated
09/23/25
Unknown Analyst
SPDBNot Ranked
SPDB
HK$21
Buy
78.72%
Upside
Reiterated
08/26/25
Unknown Analyst
CICCNot Ranked
CICC
HK$12.41
Buy
5.62%
Upside
Reiterated
05/21/25
Best Analysts Covering InnoCare Pharma Ltd.
3 Months
xxx
Success Rate
2/4 ratings generated profit
Average Return
+45.13%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +45.13% per trade.
1 Year
2 Years
xxx
Success Rate
3/4 ratings generated profit
Average Return
+82.80%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +82.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
9969 Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
2
1
1
2
2
Buy
3
1
0
1
1
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
2
1
3
3
Each month's total comprises the sum of three months' worth of ratings.
9969 Financial Forecast
9969 Stock Forecast FAQ
What is HK:9969’s average 12-month price target, according to analysts?
Based on analyst ratings, InnoCare Pharma Ltd.’s 12-month average price target is 19.86.
What is HK:9969’s upside potential, based on the analysts’ average price target?
InnoCare Pharma Ltd. has 68.98% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is InnoCare Pharma Ltd. a Buy, Sell or Hold?
InnoCare Pharma Ltd. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is InnoCare Pharma Ltd.’s share price target?
The average share price target for InnoCare Pharma Ltd. is 19.86. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$21.40 ,and the lowest forecast is HK$18.31. The average share price target represents 68.98% Increase from the current price of HK$11.75.
The highest analyst share price target is HK$21.40 ,and the lowest forecast is HK$18.31. The average share price target represents 68.98% Increase from the current price of HK$11.75.
What do analysts say about InnoCare Pharma Ltd.?
InnoCare Pharma Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of InnoCare Pharma Ltd.?
To buy shares of HK:9969, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.